BRIEF published on 11/12/2024 at 09:56, 9 days 4 hours ago KSB Maintains Growth Trajectory in 2024 Order Intake Sales Revenue EBIT Increase KSB Growth SupremeServ Segment
PRESS RELEASE published on 11/12/2024 at 09:51, 9 days 4 hours ago KSB continues on its growth path KSB SE & Co. KGaA reports growth in order intake, sales revenue, and EBIT for the first nine months of 2024. Strong performance by the KSB SupremeServ Segment drives development EBIT Order Intake Sales Revenue Growth KSB
BRIEF published on 07/31/2024 at 09:11, 3 months 21 days ago KSB Achieves Solid Growth in First Half of 2024 Despite Economic Challenges Order Intake Sales Revenue Financial Growth KSB SupremeServ Earnings (EBIT)
PRESS RELEASE published on 07/31/2024 at 09:06, 3 months 21 days ago KSB achieves solid growth in the first half of 2024 – undeterred by the economic headwind KSB reports solid growth in H1 2024, with increased order intake, sales revenue, and EBIT; SupremeServ Segment excels. Annual forecast confirmed EBIT Order Intake KSB Solid Growth H1 2024
BRIEF published on 05/08/2024 at 17:00, 6 months 12 days ago KSB SE & Co. KGaA Announces Record Results and Strategic Plans at Annual General Meeting Dividend Increase KSB SE & Co. KGaA Financial Results 2023 2024 Financial Outlook Investment Plans
PRESS RELEASE published on 05/08/2024 at 16:55, 6 months 12 days ago Record Figures at KSB’s Annual General Meeting KSB SE & Co. KGaA achieved record figures at its Annual General Meeting, with significant increases in order intake, sales revenue, and earnings. The company announced a dividend of €26.00 per ordinary share Annual General Meeting Financial Performance Dividend KSB SE & Co. KGaA Record Figures
BRIEF published on 04/25/2024 at 09:14, 6 months 26 days ago KSB Continues Positive Growth in Q1 2024 Despite Global Economic Challenges KSB Financial Growth Quarterly Performance 2024 Pump And Valve Manufacturing Global Economic Impact Corporate Earnings Report
PRESS RELEASE published on 04/25/2024 at 09:09, 6 months 26 days ago KSB continues the positive trend of the previous year in the first quarter of 2024 KSB SE & Co. KGaA continues positive trend with strong order intake, sales revenue, and earnings growth in the first quarter of 2024 Order Intake Sales Revenue KSB SE & Co. KGaA Earnings Growth Positive Trend
BRIEF published on 03/26/2024 at 10:15, 7 months 26 days ago KSB Ends 2023 with Unprecedented Financial Success Financial Performance Dividend Proposal Record Revenue Annual Report 2023 KSB
PRESS RELEASE published on 03/26/2024 at 10:10, 7 months 26 days ago KSB closes the 2023 financial year with record performance KSB closed the 2023 financial year with record performance, achieving high order intake, sales revenue, and earnings, along with an increased EBIT margin. The dividend proposal is €26.00 per ordinary share Financial Year EBIT Margin Dividend Proposal KSB Record Performance
Published on 11/21/2024 at 13:30, 31 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 31 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 1 minute ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 1 minute ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 1 minute ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 26 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 46 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 3 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 41 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 16 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 16 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
